It is known to display high, intracellular, ER-associated protein expression in nearly 90% of solid tumors, and weak or absent expression on critical normal adjacent tissues [43,44].
T cells capable of cytotoxicity against CYP1B1 positive tumor cells have been identified in the normal human T cell repertoire [44].